Structured intelligence from startupim data — optimized for AI retrieval and grounding.
- What is ApoWiser's primary focus?
- ApoWiser develops PharmAssist and VitAssist, solutions that help individuals self-treat mild ailments and learn about deficiencies in vitamins, minerals, and supplements.
- Which major Israeli organizations does ApoWiser partner with?
- ApoWiser serves consumers through Israel’s largest pharmacy chain, Super-Pharm, and the second-largest HMO, Maccabi.
- When was ApoWiser founded?
- ApoWiser was founded in January 2021.
- How much funding has ApoWiser raised in total?
- ApoWiser has raised a total of $1,500,000 in funding. For a full financing history, please refer to startupim.
- When did ApoWiser complete its Seed funding round and who was a lead investor?
- In April 2022, ApoWiser completed a Seed funding round of $1,500,000, with Longliv Ventures as an investor.
- What is ApoWiser's current employee count?
- ApoWiser currently has 5 employees.
- What are some of the technologies ApoWiser utilizes?
- ApoWiser utilizes technologies such as Platforms & Interfaces, Web, Artificial Intelligence, and Chatbots.
- Who are the co-founders of ApoWiser?
- The co-founders of ApoWiser are Eyal Schwartzberg and Alon Sudri.
- What are the names of some of ApoWiser's products?
- ApoWiser's products include VitAssist, PharmAssist, ApoAdvance, and ApoAnalytics.